http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1865961-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a70b05f3bdf7f6e9aaf7a41ac3aacdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
filingDate 2006-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1123226b83f0f36c7474bc5216e4018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ac6f1515b351302e8bb3a0a502a6caa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a86d0450197b153ce4b954fe8ac9eca
publicationDate 2007-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1865961-A1
titleOfInvention Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
abstract A method for the treatment of recurrent herpes labialis in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of penciclovir or famciclovir, or a pharmaceutically acceptable salt thereof for a period of one day.
priorityDate 2005-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415919
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID2725057
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226501885
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128301646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128610196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10335
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2725057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128045545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71353970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451074251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226887900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135524782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553844
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136415176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398748

Total number of triples: 52.